Gα i-1 is a member of the G protein alpha subunit family, specifically falling under the Gi subclass. G proteins, which are heterotrimeric in nature, are crucial intermediaries in cellular signaling, especially in processes initiated by G protein-coupled receptors (GPCRs). Upon activation by a GPCR, the Gα subunit, like Gα i-1, exchanges its bound GDP for GTP, causing it to dissociate from the beta and gamma subunits. This activated form of the Gα i-1 protein can then engage with and modulate the activity of various downstream effectors. Notably, Gα i-1 is recognized for its ability to inhibit adenylate cyclase, leading to a decrease in intracellular cyclic AMP (cAMP) levels. Through its actions, Gα i-1 plays a pivotal role in a myriad of physiological processes, and its precise regulation is imperative for maintaining cellular homeostasis. Dysregulation or aberrant signaling via Gα i-1 can contribute to various cellular disturbances.
Gα i-1 inhibitors are a class of chemical compounds crafted to specifically target and modulate the activity of the Gα i-1 protein. These inhibitors function by preventing the activation of Gα i-1, either by hindering its interaction with GPCRs or by obstructing the GDP/GTP exchange process. Depending on their mechanism of action, some inhibitors might bind directly to the Gα i-1 protein, inducing conformational changes that keep it in an inactive state. Others may interfere with the protein's ability to interact with its downstream effectors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin ADP-ribosylates Gα i-1, preventing its interaction with G protein-coupled receptors, thereby inhibiting its signal transduction. | ||||||
NF 023 | 104869-31-0 | sc-204124 sc-204124A | 10 mg 50 mg | $161.00 $629.00 | 1 | |
NF023 is a selective antagonist of Gα i-1. By binding to Gα i-1, it disrupts the protein's normal signaling processes. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $510.00 | ||
YM-254890 specifically inhibits Gα i-1 activation by preventing the exchange of GDP for GTP. | ||||||
(R)-(-)-3-Quinuclidinyl benzilate | 62869-69-6 | sc-264196 | 5 mg | $166.00 | ||
QNB is a muscarinic receptor antagonist that can indirectly inhibit Gα i-1 signaling by blocking receptor activation. | ||||||
Gallein | 2103-64-2 | sc-202631 | 50 mg | $85.00 | 20 | |
Gallein binds to Gβγ subunits, which can indirectly affect Gα i-1 activation and signaling. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin inhibits G protein signaling by preventing the interaction between Gα i-1 and its receptors. | ||||||
VU 0238429 | 1160247-92-6 | sc-301975 sc-301975A | 5 mg 25 mg | $74.00 $297.00 | ||
VU 0238429 is a known inhibitor of Gα i-1 signaling pathways, although its exact mechanism of action is still under study. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
SecinH3 inhibits Gα i-1 by disrupting its interaction with cytohesins, leading to decreased signaling activity. | ||||||